Cancer Science & Therapy

Eliza Ng has received MPH, Health Polciy and Management from Columbia University, Mailman School of Public Health, USA. She is MD, Medicine from Drexal University School of Medicine. She is working as a Senior Medical Director in Care Management Organization of Montefiore Health System. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study. Her research interests reflect in her wide range of publications in various national and international journals. She serves as a member of various associations apart from being an author for many books

Cancer Care, Management, Medicine

Xiaofeng Shi has completed her PhD from Shanghai Jiaotong University and postdoctoral studies from Shanghai Jiaotong University School of Medicine. She is the director of Department of Hematology, the Second Affiliated Hospital of Nanjing Medical University. She has published more than 16 papers in reputed journals.

Acute Myeloid Leukemia, Hematology

Elif Sarinay Cenik received her BS in Molecular Biology and Genetics from Bilkent University in Turkey, followed by her PhD in Biochemistry and Molecular Pharmacology at the University of Massachusetts Medical School under the tutelage of Dr. Phillip D. Zamore. She then completed postdoctoral training with Nobelist Dr. Andrew Z. Fire in Genetics and Pathology at Stanford University.

Cancers, Hematological Defects combined with increased cancer risk

She received further training in several countries, including as a clinical observer and trainee in bone marrow transplantation at the University of Pittsburgh School of Medicine/ UPMC Children’s Hospital of Pittsburgh in Pittsburgh, Pennsylvania, USA. She also earned her master degree about tumour immunology at the Cancer Institute of Hacettepe University Faculty of Medicine in Ankara. She is currently working at Department of paediatric haematology in Medical School of Gazi University, Ankara, Turkey.

Paediatric Haematology, Tumour Immunology

Yanzhen Wan has her expertise in clinical finding and evaluation of new diagnostic biomarkers. She has found that D-dimer combined with CRP could be identified as suitable biomarkers for differentiating between simple and other severe appendicitis, which will provide important guidance for clinicians to determine the follow-up management of acute appendicitis. And in another research, she concluded that Serum ChE level could be identified as a potential simple, rapid, convenient, non-invasive and inexpensive biomarker for differentiating between GC and benign gastric dis-eases. This will help physicians predict the probability of GC and determine whether further invasive examinations should be performed

Biomarkers, Cancers

Dr. Berrah is professor of internal medicine at Algiers Medical school and head of internal medicine department at University Hospital Bab El Oued. His internship and residency in internal medicine were performed at the University Hospital Mustapha Pacha Algiers where he spent several years as Associate Professor. He has authored or co-authored over 300 publications. He serves as principal investigator or investigator in many studies (PRAMIAL, ICLPS, LIRA Ramadan, Xalia LEA, Vision) He is member of an advisory board or a scientific board, Speaker, consultant near several laboratories of the pharmaceutical industry.

Autoimmune diseases, vascular disease, non-communicable diseases, hypertension and diabetes

BREAST SURGEON - HEAD AND CHAIRMAN OF BREAST UNIT METAXA MEMORIAL ANTI

BREAST SURGEON

Dr. Hyoung K. Lee is Associate Professor and Chair of Nuclear Engineer

His research area includes radiation detector design

Dr Mari Aparici, MD is a Clinical Professor at Stanford University. She is a Nuclear Physician with residencies in both Europe (Barcelona) and US (Stanford), and with Molecular imaging fellowships from Stanford University. She is a physician-scientist in the development of Molecular Imaging. She has more than 20 years of clinical and research experience in the field, more than 10 years of a leadership position as Chief Nuclear Medicine at the San Francisco VAMC as part of her prior appointment as a UCSF faculty member, and now as Head of the Theranostics and Nuclear Therapies program at Stanford University. She has published more than 100 papers in reputed journals, has been serving as an editorial board member of reputed journals, has been PI of NIH and non-NIH grants and serves as a member of several to committees at her University and several Societies.

Clinical Focus on Radiology & Nuclear Medicine

Olivier E. Pardo graduated from the Faculty of Pharmacy Paris-V, France where he was awarded a Doctorate in Industrial Pharmacy (1997). He then completed his PhD in Biochemistry and Molecular Biology at Imperial College-London (2002). He obtained post-doctoral experience in the laboratory of Prof. Julian Downward at the CRUK-London Research Institute where he worked on the regulation of apoptotic cell death and cell migration. In 2006, he created the Cellular Regulatory Networks lab at Imperial College, Department of Surgery and Cancer. His team focuses on understanding the molecular mechanisms underlying chemo-resistance and metastasis in lung and other cancers.

Focuses on understanding the molecular mechanisms underlying chemo-resistance and metastasis in lung and other cancers